Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars

D'Hollander, AntoineAntoineD'HollanderJans, HildeHildeJansVande Velde, GreetjeGreetjeVande VeldeVerstraete, CharlotteCharlotteVerstraeteMassa, SamSamMassaStakenborg, TimTimStakenborgMuyldermans, SergeSergeMuyldermansLagae, LiesbetLiesbetLagaeHimmelreich, UweUweHimmelreich2021-10-242021-10-2420170142-9612https://imec-publications.be/handle/20.500.12860/28243Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostarsJournal articlehttp://dx.doi.org/10.1016/j.biomaterials.2017.01.007